Biogen Names Michel Vounatsos Chief Executive Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Biogen Names Michel Vounatsos Chief Executive Officer
December 20, 2016 12:21 PM EST
Baird analsyt Brian Skorney has no change in his outlook to his Biogen (NASDAQ: BIIB) outlook after the company announced a new CEO. The analsyt also notes his strong commercial background.
Skorney commented, "After a months-long CEO search, Biogen announced appointment of Michel... More
December 20, 2016 10:59 AM EST
Mizuho analyst Salim Syed weighed in on Biogen (NASDAQ: BIIB) with shares trading up on the new CEO announcement; contrary to the view of many on the Street that shares would trade down on the notion M&A would be taken... More
December 19, 2016 5:42 PM EST
BMO Capital analyst M. Ian Somaiya weighed in on Biogen (NASDAQ: BIIB) after the company named Michel Vounatsos CEO. The analyst said the appointment doesn't take M&A off the table.
Somaiya commented, "We believe Michel Vounatsos brings significant commercial... More
